BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12706099)

  • 1. Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles.
    Adamson CS; Nermut M; Jones IM
    Virology; 2003 Mar; 308(1):157-65. PubMed ID: 12706099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
    Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
    J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of human immunodeficiency virus particles assembled from the gag precursor protein requires in situ processing by gag-pol protease.
    Ross EK; Fuerst TR; Orenstein JM; O'Neill T; Martin MA; Venkatesan S
    AIDS Res Hum Retroviruses; 1991 May; 7(5):475-83. PubMed ID: 1873082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.
    Karacostas V; Wolffe EJ; Nagashima K; Gonda MA; Moss B
    Virology; 1993 Apr; 193(2):661-71. PubMed ID: 7681610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM; Bloom G; Rose SL; Pomeroy SM; O'Brien PO; Perez EE; Sleasman JW; Dunn BM
    Virology; 2002 Jan; 292(1):137-49. PubMed ID: 11878916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW; Chiu HC; Liao WH; Wang FD; Chen SS; Wang CT
    Virology; 2004 Jan; 318(2):534-41. PubMed ID: 14972522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain.
    Zybarth G; Kräusslich HG; Partin K; Carter C
    J Virol; 1994 Jan; 68(1):240-50. PubMed ID: 8254734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S; Yang QE; O'Neill D; Yoshimura K; Nagashima K; Mitsuya H
    J Virol; 2000 May; 74(10):4621-33. PubMed ID: 10775598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.
    Yu FH; Huang KJ; Wang CT
    J Virol; 2017 May; 91(10):. PubMed ID: 28250114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the human immunodeficiency virus type 1 p6Gag domain result in reduced retention of Pol proteins during virus assembly.
    Yu XF; Dawson L; Tian CJ; Flexner C; Dettenhofer M
    J Virol; 1998 Apr; 72(4):3412-7. PubMed ID: 9525672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of human immunodeficiency virus type 1 (HIV-1) protease inhibitors from preparations of immature HIV-1 virions does not result in an increase in infectivity or the appearance of mature morphology.
    Humphrey RW; Ohagen A; Davis DA; Fukazawa T; Hayashi H; Höglund S; Mitsuya H; Yarchoan R
    Antimicrob Agents Chemother; 1997 May; 41(5):1017-23. PubMed ID: 9145862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A block in virus-like particle maturation following assembly of murine leukaemia virus in insect cells.
    Adamson CS; Davies A; Soneoka Y; Nermut M; Mitrophanous K; Jones IM
    Virology; 2003 Sep; 314(2):488-96. PubMed ID: 14554078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Establishment and application of a high-throughput screening assay for premature activation of HIV-1 precursors].
    Zhang Q; Li XY; Liu ZL; Jia PP; Wei XL; Zhao LX; Jiang JD; Cen S
    Yao Xue Xue Bao; 2010 Feb; 45(2):247-52. PubMed ID: 21351435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing sites in the human immunodeficiency virus type 1 (HIV-1) Gag-Pro-Pol precursor are cleaved by the viral protease at different rates.
    Pettit SC; Lindquist JN; Kaplan AH; Swanstrom R
    Retrovirology; 2005 Nov; 2():66. PubMed ID: 16262906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
    Accola MA; Strack B; Göttlinger HG
    J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two novel inhibitors of the human immunodeficiency virus protease on the maturation of the HIV gag and gag-pol polyproteins.
    Overton HA; McMillan DJ; Gridley SJ; Brenner J; Redshaw S; Mills JS
    Virology; 1990 Nov; 179(1):508-11. PubMed ID: 2219737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH; Wang CT
    Virology; 2004 Nov; 329(1):180-8. PubMed ID: 15476885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive regions of pol are required for efficient human immunodeficiency virus polyprotein processing and particle maturation.
    Quillent C; Borman AM; Paulous S; Dauguet C; Clavel F
    Virology; 1996 May; 219(1):29-36. PubMed ID: 8623542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.